Key result
Review evaluates procedural efficiency and safety of HPSD versus conventional ablation for AF.
Why the study?
The procedural complexity, time consumption, and unsatisfactory long-term outcomes of conventional RFCA for AF motivate evaluation of the high-power short-duration approach.
Does high-power short-duration radiofrequency ablation improve procedural efficiency, safety, and clinical outcomes compared to conventional ablation in patients with atrial fibrillation?
Does high-power short-duration radiofrequency ablation improve procedural efficiency, safety, and clinical outcomes compared to conventional ablation in patients with atrial fibrillation?
This review summarizes the current evidence on the efficiency, safety, and efficacy of high-power short-duration radiofrequency ablation for atrial fibrillation.
No quantitative synthesis of high-power short-duration ablation; leaves open whether it improves efficiency or outcomes versus conventional approaches.
Pulmonary vein isolation (PVI) is the cornerstone therapy of atrial fibrillation (AF). Radiofrequency catheter ablation (RFCA) is performed using a point-by-point method to achieve durable PVI. However, this procedure remains complex and time-consuming, and the long-term clinical outcomes are still not satisfactory. Recently, there has been increasing interest in the clinical application of high-power short-duration (HPSD) approaches in the field of RFCA. HPSD ablation, distinguishing it from the conventional ablation strategy, delivers RF energy at a high power and saves the dwell time at each site. It is unknown whether the HPSD approach can bring some gratifying changes in the field of RF energy ablation. A number of experimental studies and clinical studies have been conducted regarding this topic. The review aimed to summarize the research findings and evaluate the procedural efficiency, safety, and clinical outcomes of the HPSD approach based on the evidence available to date.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2021) conducted a review in Atrial Fibrillation. High-power short-duration (HPSD) radiofrequency ablation vs. Conventional ablation strategy was evaluated on Procedural efficiency, safety, and clinical outcomes. This review evaluates the procedural efficiency, safety, and clinical outcomes of high-power short-duration radiofrequency ablation for atrial fibrillation, with no quantitative results reported in the abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: